NEURONETICS INC(NASDAQ:STIM) stock News

STIM Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Neuronetics

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

17 days ago - By: Benzinga - Mentions: SNWV ONMD ORMP TXMD ...

12 Health Care Stocks Moving In Monday's After-Market Session

a month ago - By: Neuronetics

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

a month ago - By: Neuronetics

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

3 months ago - By: Benzinga - Mentions: AFG CXDO YUM PACK ...

Earnings Scheduled For August 5, 2025

3 months ago - By: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Zacks Investment Research - Mentions: TNDM

Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates

3 months ago - By: Neuronetics

Neuronetics Reports Second Quarter 2025 Financial and Operating Results

3 months ago - By: Neuronetics

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

3 months ago - By: Neuronetics

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

3 months ago - By: Neuronetics

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

3 months ago - By: Neuronetics

Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call

3 months ago - By: Neuronetics

Neuronetics Appoints New Chief Financial Officer

4 months ago - By: Yahoo Finance

Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting

4 months ago - By: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Neuronetics

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program

5 months ago - By: Neuronetics

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program

5 months ago - By: Neuronetics

Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes

5 months ago - By: Neuronetics

Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month

5 months ago - By: Neuronetics

Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month

6 months ago - By: Zacks Investment Research - Mentions: GMED

Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates

6 months ago - By: Neuronetics

Neuronetics Reports First Quarter 2025 Financial and Operating Results

6 months ago - By: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

6 months ago - By: Yahoo Finance - Mentions: DHI CMG

Why Neuronetics, Inc. (STIM) is Surging in 2025

6 months ago - By: Neuronetics

Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call

7 months ago - By: Neuronetics

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

7 months ago - By: Neuronetics

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

7 months ago - By: Neuronetics

Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results

8 months ago - By: Neuronetics

Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

8 months ago - By: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

8 months ago - By: Neuronetics

Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call

9 months ago - By: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

9 months ago - By: Neuronetics

NEURONETICS INC (STIM) Stock News

STIM Latest News, Press Relases and Analysis

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

12 Health Care Stocks Moving In Monday's After-Market Session

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

Earnings Scheduled For August 5, 2025

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates

Neuronetics Reports Second Quarter 2025 Financial and Operating Results

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call

Neuronetics Appoints New Chief Financial Officer

Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program

Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program

Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes

Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month

Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month

Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates

Neuronetics Reports First Quarter 2025 Financial and Operating Results

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Why Neuronetics, Inc. (STIM) is Surging in 2025

Neuronetics to Report First Quarter 2025 Financial and Operating Results and Host Conference Call

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

Evernorth Health Services, a Cigna Company, Expands NeuroStar® TMS Coverage for Adolescents Struggling with Depression

Neuronetics Reports Updated Fourth Quarter and Full Year 2024 Financial and Operating Results

Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock